AU1243101A - High dose folic acid for the treatment of hyperhomocysteinemia - Google Patents

High dose folic acid for the treatment of hyperhomocysteinemia

Info

Publication number
AU1243101A
AU1243101A AU12431/01A AU1243101A AU1243101A AU 1243101 A AU1243101 A AU 1243101A AU 12431/01 A AU12431/01 A AU 12431/01A AU 1243101 A AU1243101 A AU 1243101A AU 1243101 A AU1243101 A AU 1243101A
Authority
AU
Australia
Prior art keywords
hyperhomocysteinemia
treatment
folic acid
high dose
dose folic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU12431/01A
Inventor
Christopher S. Wilcox
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cary Pharmaceuticals Inc
Original Assignee
Cary Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cary Pharmaceuticals Inc filed Critical Cary Pharmaceuticals Inc
Publication of AU1243101A publication Critical patent/AU1243101A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU12431/01A 1999-10-28 2000-10-30 High dose folic acid for the treatment of hyperhomocysteinemia Abandoned AU1243101A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US16190899P 1999-10-28 1999-10-28
US60161908 1999-10-28
PCT/US2000/029788 WO2001030352A1 (en) 1999-10-28 2000-10-30 High dose folic acid for the treatment of hyperhomocysteinemia

Publications (1)

Publication Number Publication Date
AU1243101A true AU1243101A (en) 2001-05-08

Family

ID=22583314

Family Applications (1)

Application Number Title Priority Date Filing Date
AU12431/01A Abandoned AU1243101A (en) 1999-10-28 2000-10-30 High dose folic acid for the treatment of hyperhomocysteinemia

Country Status (2)

Country Link
AU (1) AU1243101A (en)
WO (1) WO2001030352A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2851920B1 (en) * 2003-03-06 2007-05-04 Larena Sa PRODUCT FOR REDUCING METABOLIC SYNDROME AND USE THEREOF FOR THE PREPARATION OF A FOOD OR DIETETIC COMPOSITION FOR THE PREVENTION OR TREATMENT OF METABOLIC SYNDROME
DE10357277A1 (en) * 2003-12-05 2005-06-30 Phyt-Immun Gmbh Agent for improving iron absorption
CA2582611A1 (en) * 2003-12-18 2005-06-30 London Health Sciences Centre Research Inc. Method of treating elevated plasma homocysteine levels in esrd patients
US20060217386A1 (en) * 2005-03-10 2006-09-28 Edwards John B Nutritional preparations
WO2011018472A2 (en) * 2009-08-14 2011-02-17 Basf Se Methods in cell cultures, and related inventions, employing certain additives
EP2808023A1 (en) * 2013-05-30 2014-12-03 Université Pierre et Marie Curie (Paris 6) New drug for the treatment and/or prevention of depressive disorders
WO2020092616A1 (en) * 2018-10-31 2020-05-07 Rejuvenation Therapeutics Compositions useful in the treatment of hyperhomocysteinemia

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06192105A (en) * 1992-09-14 1994-07-12 Vesta Medicines Pty Ltd Medical preparation for lowering level of homocysteine
US6008221A (en) * 1996-11-06 1999-12-28 Bristol-Myers Squibb Company Method for treating Alzheimer's disease with folic acid
US6054128A (en) * 1997-09-29 2000-04-25 Wakat; Diane Dietary supplements for the cardiovascular system

Also Published As

Publication number Publication date
WO2001030352A1 (en) 2001-05-03

Similar Documents

Publication Publication Date Title
AU2003258848A1 (en) Hyaluronic acid derivatives and processes for preparing the same
HUP0204399A3 (en) Pteridine compounds for the treatment of psoriasis, process for their preparation, pharmaceutical compositions containing them and their use
AU2754501A (en) Treatment of acne using lipoic acid
IL141295A0 (en) Use of derivatives of aryl (or heteroaryl) azolycarbinols in the manufacture of a medicament for the treatment of disorders mediated by an excess of substance p
AU6910600A (en) Methods for the treatment of mental disorders
AU7622000A (en) Compounds for the treatment of viral-mediated diseases
AU2002240359A1 (en) Pharmaceutical composition for the treatment of alopecia
AU4364400A (en) Azaindole derivatives for the treatment of depression
AU7731700A (en) Low dose ifn-gamma for treatment of disease
AU2001260834A1 (en) The treatment of herpes
AU2670600A (en) Pharmaceutical composition containing desoxypeganine for the treatment of nicotine dependence
AU1243101A (en) High dose folic acid for the treatment of hyperhomocysteinemia
AU3669700A (en) 4-aminobutanoic acid derivatives and drugs containing these derivatives as the active ingredient
HUP0103788A3 (en) Processes for the preparation of 5-hydroxy-3-oxopentanoic acid derivatives
AU2021601A (en) Composition for the treatment of dandruff
AUPQ365299A0 (en) Anthranilic acid derivatives
AU7653600A (en) Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives for the treatment of multiple sclerosis
AU7958000A (en) Process for the preparation of oxyiminoalkanoic acid derivatives
HK1043938A1 (en) Composition for the treatment of psoriasis
AU2001282410A1 (en) N-benzylindole-3-acetic acid derivatives for use in the treatment of drug resistan cancer
AU2683500A (en) Compositions for the treatment of pain
AU5416500A (en) Pharmaceutical composition for the treatment of calcification
AU4475300A (en) Tetrahydroisoquinolinyl-indole derivatives for the treatment of depression
AU2002312779A1 (en) Delta-aminolevulinic acid for the therapeutical and cosmetic use
AU7286500A (en) Pharmaceutical compositions for treating psoriasis

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase